Connection

Andrea Calcagno to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Andrea Calcagno has written about Antibodies, Monoclonal, Humanized.
Andrea Calcagno
Connection Strength
0.044
Antibodies, Monoclonal, Humanized
  1. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020 May-Jun; 38(3):529-532.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.